Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA Publications section wording change clarifies that PubMed-derived publications are auto-filled and may not all be about the study, and the footer revision indicator shows v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe site-wide funding/operating status notice has been removed from the page. The trial details shown on this page remain unchanged.SummaryDifference0.3%

- Check34 days agoChange DetectedNo additions or deletions detected; the page content remains unchanged with respect to study details, eligibility criteria, and locations.SummaryDifference0.3%

- Check62 days agoChange DetectedUpdated to v3.2.0 with an operational status notice; removed a specific disease resource (Cutaneous neuroendocrine carcinoma) and v3.1.0 reference.SummaryDifference2%

- Check69 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%

- Check84 days agoChange DetectedUpdated version from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. No changes to pricing, stock, or time slots.SummaryDifference0.1%

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.